Creative Biolabs highlights the growing importance of antibody engineering and conversion strategies in advancing ...
An essential component of this technological rollout is the AI-driven de novo antibody sequence generation service. This ...
The US National Science Foundation (NSF) has launched an investment programme to advance scientific community datasets and ...
The deadline for abstract submission (late-breaking posters) is coming up on 30 th July. The deadline for late registration ...
Chai Discovery, an AI company developing a computer-aided design suite for molecules, is collaborating with Novartis to advance the discovery of therapeutic antibodies using AI Under the collaboration ...
AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on native Outer Membrane Vesicles (nOMVs), has published first-in-human Phase I clinical data ...
Beckman Coulter Diagnostics, a specialist in clinical diagnostics and a Danaher company, has received CE Mark under IVDR for its Acess p-Tau217 assay, a blood test designed to support the clinical ...
Osteosarcoma is an aggressive bone cancer characterised by high rate of recurrence and metastasis. It is the most common primary bone cancer in children, adolescents and young adults. Symptoms include ...
CDMO partner Freudenberg Medical recently launched CleanAssure, an ISO Class 5 controlled cleanroom for sterile single-use assemblies. The cleaning and sterilisation service supports biopharmaceutical ...
A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...
Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...
Waters Corporation has launched a the Xevo MRT P10 mass spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) system for high-throughput multiomics, bioanalysis and biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results